Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of EBAG9 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human |
| Host species | Rabbit |
| Applications | IP,ELISA,IHC,WB-Ti |
More info about EBAG9 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB12726 |
| Product name: | EBAG9 polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against synthetic peptide of EBAG9. |
| Gene id: | 9166 |
| Gene name: | EBAG9 |
| Gene alias: | EB9|PDAF|RCAS1 |
| Gene description: | estrogen receptor binding site associated, antigen, 9 |
| Immunogen: | A synthetic peptide corresponding to C-terminus of human EBAG9. |
| Form: | Liquid |
| Recommend dilutions: | Western Blot (0.1-1 ug/mL) ELISA (0.01-0.1 ug/mL) Immunoprecipitation (2-5 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In TBS, pH 7.2 (BSA, 10% Proclin300) |
| Storage instruction: | Store at 4°C. For long term storage store at -20°C or lower. Aliquot to avoid repeated freezing and thawing. |
| Quality control testing: | Antibody Reactive Against Synthetic Peptide. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Specificity: | This antibody recognizes ~32 KDa EBAG9. |
| Reactivity: | Human |
| Application image: |  |
| Application image note: | The tissue lysate derived from human liver tissue lysate was immunoprobed by EBAG9 polyclonal antibody (Cat # PAB12726) at 1 : 500. An immunoreactive band is observed around ~32 kDa (1). The lane 2 is a negative control. |
| Applications: | IP,ELISA,IHC,WB-Ti |
| Shipping condition: | Dry Ice |
| Publications: | The expression of RCAS1 and tumor infiltrating lymphocytes in patients with T3 gastric carcinoma.Fukuda K, Tsujitani S, Maeta Y, Yamaguchi K, Ikeguchi M, Kaibara N. Gastric Cancer. 2002;5(4):220-7. |